Key Takeaways
- • Vastian appointed Peter Stamnes as Chief Revenue Officer to lead its go-to-market strategy and commercial teams, according to a Business Wire release dated October 28, 2026.
- • Stamnes joins from NAVEX, where he spent nearly two decades in senior sales leadership roles, bringing experience in hospital compliance software adoption at scale.
- • Vastian's platform supports more than 10,000 facilities across 60 countries and over 2.3 million clinical professionals, and is used by all of the top 20 U.S. hospitals named by U.S. News & World Report.
- • The appointment follows a strategic growth investment from Bregal Sagemount and Silversmith Capital Partners announced in May 2026.
- • The company's strategy centers on extending its established laboratory quality franchise into a connected quality and compliance platform for hospitals and health systems.
Summary
Stamnes joins from NAVEX, where he held senior sales leadership roles over nearly two decades. The company said he brings experience helping hospitals evaluate and adopt compliance software at scale and a record of developing sales teams and supporting more than 7,000 customers nationwide. His responsibilities will include strengthening go-to-market capabilities, developing commercial teams, growing Vastian's position with clinical laboratories, and driving platform adoption across hospitals and health systems.
Vastian CEO Tom Ormondroyd said laboratory and hospital leaders need technology that can meet current needs and evolve with their organizations. He said the company's long-standing laboratory presence positions it to connect quality and compliance work across the entire hospital. Stamnes said the company's established laboratory leadership, platform breadth, and growth momentum drew him to the role.
The company reports that its platform supports more than 10,000 facilities in 60 countries and serves over 2.3 million clinical professionals. It is used by all of the top 20 U.S. hospitals named by U.S. News & World Report. Vastian, formerly known as MediaLab and founded in 1995, describes itself as the fastest-growing provider of quality management software for hospitals and laboratories and is private equity backed.
The appointment follows a strategic growth investment from Bregal Sagemount and Silversmith Capital Partners announced in May 2026. The company was also named winner of the Compliance Management Innovation Award in the 2026 MedTech Breakthrough Awards, recognizing its connected quality platform for hospitals and laboratories.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.